Proteasome inhibitors in development for malaria.
Featherstone
C
C
D000349:Africa; D000818:Animals; D001897:Boronic Acids / Q000494:pharmacology / Q000627:therapeutic use; D002738:Chloroquine / Q000494:pharmacology / Q000627:therapeutic use; D003546:Cysteine Endopeptidases / Q000378:metabolism*; D004151:Dipeptides / Q000494:pharmacology / Q000627:therapeutic use; D004351:Drug Resistance / Q000235:genetics; D008288:Malaria / Q000188:drug therapy* / Q000469:parasitology; D009097:Multienzyme Complexes / Q000378:metabolism*; D010961:Plasmodium / Q000187:drug effects / Q000201:enzymology*; D010963:Plasmodium falciparum / Q000187:drug effects / Q000201:enzymology; D046988:Proteasome Endopeptidase Complex; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use
D001897:Boronic Acids; D004151:Dipeptides; D009097:Multienzyme Complexes; D015842:Serine Proteinase Inhibitors; D002738:Chloroquine; D003546:Cysteine Endopeptidases; D046988:Proteasome Endopeptidase Complex